1. Home
  2. CVRX vs BNY Comparison

CVRX vs BNY Comparison

Compare CVRX & BNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVRX
  • BNY
  • Stock Information
  • Founded
  • CVRX 2000
  • BNY 2001
  • Country
  • CVRX United States
  • BNY United States
  • Employees
  • CVRX N/A
  • BNY N/A
  • Industry
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BNY Trusts Except Educational Religious and Charitable
  • Sector
  • CVRX Health Care
  • BNY Finance
  • Exchange
  • CVRX Nasdaq
  • BNY Nasdaq
  • Market Cap
  • CVRX 203.9M
  • BNY 230.8M
  • IPO Year
  • CVRX 2021
  • BNY N/A
  • Fundamental
  • Price
  • CVRX $7.17
  • BNY $10.13
  • Analyst Decision
  • CVRX Buy
  • BNY
  • Analyst Count
  • CVRX 7
  • BNY 0
  • Target Price
  • CVRX $14.00
  • BNY N/A
  • AVG Volume (30 Days)
  • CVRX 165.0K
  • BNY 52.7K
  • Earning Date
  • CVRX 10-28-2025
  • BNY 01-01-0001
  • Dividend Yield
  • CVRX N/A
  • BNY 3.93%
  • EPS Growth
  • CVRX N/A
  • BNY N/A
  • EPS
  • CVRX N/A
  • BNY N/A
  • Revenue
  • CVRX $54,652,000.00
  • BNY N/A
  • Revenue This Year
  • CVRX $11.32
  • BNY N/A
  • Revenue Next Year
  • CVRX $18.58
  • BNY N/A
  • P/E Ratio
  • CVRX N/A
  • BNY N/A
  • Revenue Growth
  • CVRX 23.11
  • BNY N/A
  • 52 Week Low
  • CVRX $4.30
  • BNY $8.60
  • 52 Week High
  • CVRX $18.55
  • BNY $10.80
  • Technical
  • Relative Strength Index (RSI)
  • CVRX 44.88
  • BNY 75.59
  • Support Level
  • CVRX $6.53
  • BNY $9.39
  • Resistance Level
  • CVRX $8.35
  • BNY $10.24
  • Average True Range (ATR)
  • CVRX 0.47
  • BNY 0.10
  • MACD
  • CVRX -0.11
  • BNY 0.04
  • Stochastic Oscillator
  • CVRX 35.16
  • BNY 85.14

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About BNY BlackRock New York Municipal Income Trust

Blackrock NY Municipal Income Tr investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.

Share on Social Networks: